The Precision Peptide Genetic Test ($298) analyzes 14 metabolic pathways and 150+ genetic insights related to appetite, GLP-1 sensitivity, and weight regulation
Typical Anthem prior authorization requirements for weight loss GLP-1 medications include a BMI of 30 or above, or a BMI of 27 or above with at least one qualifying weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea
*Average 15% weight loss was seen with semaglutide in the Step 1 trial at 2.4 mg dosing available with Wegovy - Ozempic is available only up to 2.0 mg
American society of clinical oncology
Kobori T, Onishi Y, Yoshida Y, et al
According to the CDC (Centers for Disease Control and Prevention), the prevalence of obese population in the U.S